We focused on fibroblast growth factor 1 (FGF1) and its receptor (FGFR), a member of receptor tyrosine kinase family (RTKs), as its overexpression or aberrant activation has been reported in breast [1,2], lung [3], and gastric cancers [4]. The gene discussed is FGF1; the disease is gastric cancer.